Information Journal Paper
APA:
Copy. (2018). AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial. PLOS ONE, 13(1), 0-0. SID. https://sid.ir/paper/770263/en
Vancouver:
Copy. AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial. PLOS ONE[Internet]. 2018;13(1):0-0. Available from: https://sid.ir/paper/770263/en
IEEE:
Copy, “AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial,” PLOS ONE, vol. 13, no. 1, pp. 0–0, 2018, [Online]. Available: https://sid.ir/paper/770263/en